These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 12085911)
41. The role of institutional review boards in protecting human subjects: are we really ready to fix a broken system? Beh HG Law Psychol Rev; 2002; 26(1):1-47. PubMed ID: 16514756 [No Abstract] [Full Text] [Related]
42. Ethical considerations in human investigation involving paradigm shifts: organ transplantation in the 1990s. Schaffner KF IRB; 1997; 19(6):5-10. PubMed ID: 11656911 [No Abstract] [Full Text] [Related]
43. Recommendations for federal "super agency" would affect institutional review boards. Maloney DM Hum Res Rep; 2001 Feb; 16(2):1-3. PubMed ID: 12530378 [No Abstract] [Full Text] [Related]
44. Thinking further about value: commentary on "A taxonomy of value in clinical research". Grady C IRB; 2002; 24(6):7-8. PubMed ID: 12683395 [No Abstract] [Full Text] [Related]
45. Monitoring of outside research. Cantor D; Meyers K IRB; 1983; 5(2):10. PubMed ID: 11653518 [No Abstract] [Full Text] [Related]
46. A taxonomy of value in clinical research. Casarett DJ; Karlawish JH; Moreno JD IRB; 2002; 24(6):1-6. PubMed ID: 12683394 [No Abstract] [Full Text] [Related]
48. Module five: implementation of ethics review. Dhai A Dev World Bioeth; 2005 Mar; 5(1):73-91. PubMed ID: 15748179 [TBL] [Abstract][Full Text] [Related]
49. The Institutional Review Board: a case study of no-risk decisions in health-related research. Gortner SR; Heath E; Sanders P Nurs Res; 1981; 30(1):21-4. PubMed ID: 6906010 [No Abstract] [Full Text] [Related]
50. Institutional review boards (IRBs) and risk considerations for children. Maloney DM Hum Res Rep; 2004 Sep; 19(9):1-3. PubMed ID: 15675081 [No Abstract] [Full Text] [Related]
51. Guide to decision-making in institutional review of proposals for human experimentation. Himmelsbach CK; Sliwinski AJ; Lorber M; Mossman KL Man Med; 1978; 3(3):201-9. PubMed ID: 10316736 [No Abstract] [Full Text] [Related]
52. The IRB's monitoring function: four concepts of monitoring. Heath EJ IRB; 1979; 1(5):103+. PubMed ID: 11661758 [No Abstract] [Full Text] [Related]
53. Ethical considerations in the publication of the results of research involving human subjects. Levine RJ Clin Res; 1973 Oct; 21(4):763-7. PubMed ID: 11660968 [No Abstract] [Full Text] [Related]
54. Connecticut "watchdogs" human research experiments. Alberts L; DeRiemer TA Am J Correct; 1973; 35(2):40-4. PubMed ID: 11661238 [No Abstract] [Full Text] [Related]
55. Ten questions institutional review boards should ask when reviewing international clinical research protocols. Fitzgerald DW; Wasunna A; Pape JW IRB; 2003; 25(2):14-8. PubMed ID: 12833903 [No Abstract] [Full Text] [Related]
56. When to start, when to stop a randomized trial. Best WR IRB; 1985; 7(6):10. PubMed ID: 11649687 [No Abstract] [Full Text] [Related]
57. Rationalizing risk assessment in human subject research. Coleman CH Ariz Law Rev; 2004; 46(1):1-51. PubMed ID: 16189913 [No Abstract] [Full Text] [Related]
58. Thin line between research and audit. Choo V Lancet; 1998 Aug; 352(9125):337-8. PubMed ID: 9717915 [No Abstract] [Full Text] [Related]
59. Multi-institutional review of a genetic counseling study. Kavanagh Ce IRB; 1979 Apr; 1(2):1-3+. PubMed ID: 11661639 [No Abstract] [Full Text] [Related]
60. Sexual relations between psychotherapists and their patients: toward research or restraint. Riskin LL Calif Law Rev; 1979 Jul; 67(4):1000-27. PubMed ID: 11661927 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]